Hillstream BioPharma | Investor Presentation Deck

Hillstream BioPharma | Investor Presentation Deck | 19 slides

Hillstream BioPharma · 2023-07

arc beats above · slides in the middle · loops below · scroll → 1 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 16 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits

— 0/2 slides

50% 1/2 slides 100% 2/2 slides · 5 hits 100% 2/2 slides Solution 11 slides 100% 11/11 slides 100% 11/11 slides · 47 hits

— 0/11 slides

27.3% 3/11 slides 18.2% 2/11 slides 100% 11/11 slides · 14 hits 18.2% 2/11 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits

— 0/1 slides

100% 1/1 slides · 3 hits 100% 1/1 slides Team 2 slides 100% 2/2 slides 100% 2/2 slides · 11 hits

— 0/2 slides

100% 2/2 slides

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Slide inventory

every slide · same image gating as the playbook

front_matter

Open slide detail

other

Open slide detail

The slide uses a patient testimonial/photo to ground the mission statement in real-world impact.inspire_vision

Open slide detail

The slide uses a structured table-like layout to present scientific rationale (Background, Opportunity, Target Validation) followed by a summary box for the leapresent_solution

Open slide detailBeat · Solution

The slide uses a Gantt-style visual for the 'Pre-clinical' stage, though it is not a full timeline.plan_implementation

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The slide combines market sizing (patient counts) with competitive intelligence (deal table).size_opportunity

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The slide uses a horizontal timeline with milestones mapped to specific quarters.plan_implementation

Open slide detailBeat · Solution

The diagram illustrates the binding mechanism of the antibody to the cell surface receptors.present_solution

Open slide detailBeat · Solution

Technical scientific slide showing protein structure and domain mapping.present_solution

Open slide detailBeat · Solution

The slide uses a structural biology diagram to differentiate the binding mechanism of the company's asset from standard-of-care antibodies.present_solution

Open slide detailBeat · Solution

Scientific illustration of a bispecific antibody binding to a HER2-HER3 dimer.present_solution

Open slide detailBeat · Solution

The slide uses a visual representation of an ADC molecule to explain the components and the therapeutic mechanism.present_solution

Open slide detailBeat · Solution

The slide explains the biological mechanism of the drug candidate HSB-3215.present_solution

Open slide detailBeat · Solution

The slide uses a structural biology comparison between human and bovine antibody structures to highlight the unique 'knob' domain.present_solution

Open slide detailBeat · Solution

The slide uses a table to compare market incumbents with the company's pipeline asset, followed by a structural biology illustration.compare_peers